Edition:
United States

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.46USD
18 Jun 2018
Change (% chg)

$-0.01 (-3.11%)
Prev Close
$0.47
Open
$0.46
Day's High
$0.46
Day's Low
$0.46
Volume
975
Avg. Vol
49,464
52-wk High
$2.91
52-wk Low
$0.32

Chart for

About

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of... (more)

Overall

Beta: 1.46
Market Cap(Mil.): $19.94
Shares Outstanding(Mil.): 43.54
Dividend: --
Yield (%): --

Financials

  IPCI.OQ Industry Sector
P/E (TTM): -- 29.97 34.18
EPS (TTM): -0.31 -- --
ROI: -662.80 13.65 13.17
ROE: -- 15.43 15.15

BRIEF-Intellipharmaceutics Received Notice From Nasdaq Hearings Panel

* INTELLIPHARMACEUTICS INTERNATIONAL - RECEIVED NOTICE FROM NASDAQ HEARINGS PANEL GRANTING REQUEST FOR CONTINUED LISTING UNTIL SEPT 28, 2018 Source text: (https://bit.ly/2rZpVwr) Further company coverage:

May 22 2018

BRIEF-Intellipharmaceutics International Received Letter From Nasdaq To Delist Co's Securities

April 23 Intellipharmaceutics International Inc :

Apr 23 2018

BRIEF-Intellipharmaceutics Announces Us$ 1.8 mln Registered Direct Offering‍​

* INTELLIPHARMACEUTICS ANNOUNCES US$ 1.8 MILLION REGISTERED DIRECT OFFERING‍​

Mar 19 2018

BRIEF-Intellipharmaceutics Meets With FDA Regarding Oxycodone Er NDA Development Program

* INTELLIPHARMACEUTICS MEETS WITH FDA REGARDING OXYCODONE ER NDA DEVELOPMENT PROGRAM

Feb 09 2018

BRIEF-Intellipharmaceutics Provides Operational Update

* INTELLIPHARMACEUTICS - COMMERCIALIZATION OPPORTUNITIES FOR CO'S PRODUCT HAVE BEEN "CHALLENGING IN U.S. DUE TO EXTREMELY COMPETITIVE COST ENVIRONMENT"

Jan 24 2018

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $61.04 -0.99
Novartis AG (NOVN.S) CHF75.60 +0.10
Johnson & Johnson (JNJ.N) $120.76 -1.85
Pfizer Inc. (PFE.N) $36.03 -0.33

Earnings vs. Estimates